Fairmount Funds Management’s Zogenix ZGNX Stock Holding History
Bought
Maintained
Sold
Fairmount Funds Management's ZGNX Position: Q1 2022 in Review
Fairmount Funds Management sold out of Zogenix (ZGNX) in Q1 2022, closing a stake of 2,502,259 shares — an estimated $40.7M sold.
Fairmount Funds Management first reported a position in ZGNX in Q4 2019 and held it in 9 quarters. The position peaked at $40.7M in Q4 2021. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.
- Fairmount Funds Management reported no remaining Zogenix position as of Q1 2022 after selling out during the quarter.
- Fairmount Funds Management sold 2,502,259 Zogenix shares in Q1 2022, an estimated $40.7M.
- Fairmount Funds Management first reported a position in Zogenix in Q4 2019 and held it in 9 quarters.
- Fairmount Funds Management's Zogenix position peaked at $40.7M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Zogenix as of Q1 2022.
Based on Fairmount Funds Management's 13F filing for Q1 2022, filed 16 May 2022.